136 related articles for article (PubMed ID: 34567212)
1. Clinical Study on Effect of Solution Focused Approach on the Complications, Pain, Sleep, and Quality of Life in Patients with Hepatocellular Carcinoma Undergoing TACE.
Ma C; Ma Y; Lu S; Li D; Wang Y; Xu Y; Zhang T; Du Y; Wang L
Evid Based Complement Alternat Med; 2021; 2021():5068228. PubMed ID: 34567212
[TBL] [Abstract][Full Text] [Related]
2. Effect of perioperative parecoxib sodium on postoperative pain control for transcatheter arterial chemoembolization for inoperable hepatocellular carcinoma: a prospective randomized trial.
Lv N; Kong Y; Mu L; Pan T; Xie Q; Zhao M
Eur Radiol; 2016 Oct; 26(10):3492-9. PubMed ID: 26801163
[TBL] [Abstract][Full Text] [Related]
3. Quality of Life after Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation in Patients with Unresectable Hepatocellular Carcinoma Compared with Transcatheter Arterial Chemoembolization alone.
Hassanin TM; Fouad Y; Hassnine A; Eisawy M; Farag N; Abdel Ghany W
Asian Pac J Cancer Prev; 2021 Apr; 22(4):1255-1261. PubMed ID: 33906320
[TBL] [Abstract][Full Text] [Related]
4. Combination of percutaneous radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma: observation of clinical effects.
Liu HC; Shan EB; Zhou L; Jin H; Cui PY; Tan Y; Lu YM
Chin J Cancer Res; 2014 Aug; 26(4):471-7. PubMed ID: 25232222
[TBL] [Abstract][Full Text] [Related]
5. Effect of Perioperative Comprehensive Nursing Intervention on Transcatheter Arterial Chemoembolization in Patients with Primary Hepatic Carcinoma.
Hu M; Fan Z; Han Y
Evid Based Complement Alternat Med; 2022; 2022():9000331. PubMed ID: 35815267
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
Liu C; Sun L; Xu J; Zhao Y
World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
[TBL] [Abstract][Full Text] [Related]
7. Clinical Nursing Paths Benefit Patient Outcomes Undergoing Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma.
Gu J; Liang Y
Evid Based Complement Alternat Med; 2022; 2022():4655293. PubMed ID: 35769161
[TBL] [Abstract][Full Text] [Related]
8. Comparison of differences and determinants between presence and absence of sleep disturbance in hepatocellular carcinoma patients.
Chu TL; Yu WP; Chen SC; Peng HL; Wu MJ
Cancer Nurs; 2011; 34(5):354-60. PubMed ID: 21242769
[TBL] [Abstract][Full Text] [Related]
9. TACE Combined with HIFU Versus Surgical Resection for Single Hepatocellular Carcinoma with Child-Pugh B Cirrhosis in Overall Survival and Progression-Free Survival: A Retrospective Study.
Zhang Q; Wang Y; Zhang J; Zhang W; Gong J; Ma R
Technol Cancer Res Treat; 2021; 20():15330338211060180. PubMed ID: 34855560
[No Abstract] [Full Text] [Related]
10. [Clinical observation on high intensity focused ultrasound combined with transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma].
Wu Y; Li J; Zhang SJ; Zhao YF; Zhao LS; Ma XX; Feng LS; Fan ZJ
Zhonghua Wai Ke Za Zhi; 2012 Aug; 50(8):691-4. PubMed ID: 23157899
[TBL] [Abstract][Full Text] [Related]
11. Novel multimodal analgesia regimen improves post-TACE pain in patients with hepatocellular carcinoma.
Guo JG; Zhao LP; Rao YF; Gao YP; Guo XJ; Zhou TY; Feng ZY; Sun JH; Lu XY
Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):510-516. PubMed ID: 30135046
[TBL] [Abstract][Full Text] [Related]
12. Intraarterial lidocaine administration for relief of pain resulting from transarterial chemoembolization of hepatocellular carcinoma: its effectiveness and optimal timing of administration.
Lee SH; Hahn ST; Park SH
Cardiovasc Intervent Radiol; 2001; 24(6):368-71. PubMed ID: 11907741
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of short-term effects of drug-loaded microspheres and traditional transcatheter arterial chemoembolization in the treatment of advanced liver cancer.
Ye T; Shao SH; Ji K; Yao SL
World J Gastrointest Oncol; 2022 Dec; 14(12):2367-2379. PubMed ID: 36568947
[TBL] [Abstract][Full Text] [Related]
14. Short-term efficacy and safety of callispheres drug-loaded microsphere embolization in primary hepatocellular carcinoma.
Li J; Wang N; Shi C; Liu Q; Song J; Ye X
J Cancer Res Ther; 2021 Jul; 17(3):733-739. PubMed ID: 34269307
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors and an innovative nomogram model for patients with hepatocellular carcinoma treated with postoperative adjuvant transarterial chemoembolization.
Xu JX; Qin SL; Wei HW; Chen YY; Peng YC; Qi LN
Ann Med; 2023 Dec; 55(1):2199219. PubMed ID: 37070467
[TBL] [Abstract][Full Text] [Related]
16. [Quality of life of primary hepatocellular carcinoma patients after radiofrequency ablation].
Wang YB; Chen MH; Yan K; Yang W; Dai Y; Yin SS
Ai Zheng; 2005 Jul; 24(7):827-33. PubMed ID: 16004809
[TBL] [Abstract][Full Text] [Related]
17. Comparison of efficacy and safety between transarterial chemoembolization (TACE) combined with lenvatinib versus TACE combined with sorafenib in the treatment of intermediate and advanced hepatocellular carcinoma.
Xu R; Ji X; Pei X; Yu Y
Am J Transl Res; 2023; 15(2):1117-1128. PubMed ID: 36915764
[TBL] [Abstract][Full Text] [Related]
18. [Clinical effect of transcatheter arterial chemoembolization combined with high intensity focused ultrasound ablation in treatment of large hepatocellular carcinoma].
Li CX; Wu PH; Fan WJ; Huang JH; Zhang FJ; Zhang L; Gu YK; Zhao M; Gao F; Jiao DC
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(11):754-7. PubMed ID: 19595104
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of endostar combined with transcatheter arterial chemoembolization and analysis of vascular endothelial factor and C-reactive protein levels in patients with advanced hepatocellular carcinoma under contrast enhanced ultrasound.
Wang Y; Xuan Z; Zheng X; Han R; Zhou L; Liu H; Liu Y
J BUON; 2020; 25(1):407-414. PubMed ID: 32277662
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of endostar combined with transcatheter arterial chemoembolization and analysis of vascular endothelial factor and C-reactive protein levels in patients with advanced hepatocellular carcinoma under contrast enhanced ultrasound.
Wang Y; Xuan Z; Zheng X; Han R; Zhou L; Liu H; Liu Y
J BUON; 2019; 24(6):2394-2401. PubMed ID: 31983111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
